Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |